D-0145-2017 Class III Terminated
FDA drug recall D-0145-2017 was initiated by Sandoz Inc on Oct 19, 2016 and is designated Class III. Reason for recall: Labeling: Missing Label The recall status is terminated (terminated Jul 27, 2017). Affected quantity: 139,430 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 30, 2016
- Initiation Date
- Oct 19, 2016
- Termination Date
- Jul 27, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 139,430 vials
Product description
Ceftriaxone for Injection, USP, 1 gram, 10 Single use Vials, Rx only, For IM or I.V. Use, Manufactured by: Sandoz GMbH for Hospira Worldwide, Inc., Lake Forest, Il 60045, USA, Made in Austria, NDC 0409-7332-01
Reason for recall
Labeling: Missing Label
Distribution pattern
WI
Code information
Sandoz - Lot GJ7151(Pfizer- Lot 670028M); Exp. 07/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0145-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026